Search research articles
Contact Us
Filters
Showing results (51-60 of 108) with videos related to
Page
of 11
Sort By:
Journal of Cancer
|
November 21, 2017
Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma
Li-Ling Luo, Mian Xi, Ya-Di Yang, et al.
Journal of Cancer
|
September 27, 2014
The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy
Peng Zhang, Mian Xi, Qiao-Qiao Li, et al.
Plos One
|
August 19, 2014
Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma?
Peng Zhang, Mian Xi, Lei Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 10, 2015
Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma
Lei Zhao, Feng Chi, Mian Xi, et al.
Radiation Oncology (London, England)
|
November 27, 2014
Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone
Peng Zhang, Mian Xi, Lei Zhao, et al.
BMC Cancer
|
September 17, 2022
Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis
Tian-Tian Gao, Jia-Hui Shan, Yu-Xian Yang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2026
Stereotactic body radiotherapy versus hepatic resection for recurrent small hepatocellular carcinoma: A post-hoc analysis with propensity score adjustment from two randomized trials
Yizhen Fu, Shiliang Liu, Jinbin Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 6, 2015
Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma: A matched case-control study
Shi-Liang Liu, Hong Yang, Peng Zhang, et al.
JHEP Reports : Innovation in Hepatology
|
September 23, 2024
Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cm
Zhoutian Yang, Shiliang Liu, Li Hu, et al.
British Journal of Cancer
|
June 27, 2024
Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study
Ruixi Wang, Shiliang Liu, Baoqing Chen, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 108) with videos related to
Sort By:
Page
of 11
Journal of Cancer
|
November 21, 2017
Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma
Li-Ling Luo, Mian Xi, Ya-Di Yang, et al.
Journal of Cancer
|
September 27, 2014
The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapy
Peng Zhang, Mian Xi, Qiao-Qiao Li, et al.
Plos One
|
August 19, 2014
Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma?
Peng Zhang, Mian Xi, Lei Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 10, 2015
Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma
Lei Zhao, Feng Chi, Mian Xi, et al.
Radiation Oncology (London, England)
|
November 27, 2014
Efficacy and prognostic analysis of chemoradiotherapy in patients with thoracic esophageal squamous carcinoma with cervical lymph nodal metastasis alone
Peng Zhang, Mian Xi, Lei Zhao, et al.
BMC Cancer
|
September 17, 2022
Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis
Tian-Tian Gao, Jia-Hui Shan, Yu-Xian Yang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2026
Stereotactic body radiotherapy versus hepatic resection for recurrent small hepatocellular carcinoma: A post-hoc analysis with propensity score adjustment from two randomized trials
Yizhen Fu, Shiliang Liu, Jinbin Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 6, 2015
Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma: A matched case-control study
Shi-Liang Liu, Hong Yang, Peng Zhang, et al.
JHEP Reports : Innovation in Hepatology
|
September 23, 2024
Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cm
Zhoutian Yang, Shiliang Liu, Li Hu, et al.
British Journal of Cancer
|
June 27, 2024
Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II study
Ruixi Wang, Shiliang Liu, Baoqing Chen, et al.
Page
of 11